FDA approves new drug for CIC
On Jan. 29, the U.S. Food and Drug Administration (FDA) approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation. Read more
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
